| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| figitumumab | insulin-like growth factor i receptor | NA | Successful target | TTD , DGIDB | Adrenal Cancer[MeSHID:D000310] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
6.7 | discontinued in phase 1 | antagonist |
| figitumumab | insulin-like growth factor i receptor | NA | Successful target | TTD , DGIDB | Adrenal Cancer[MeSHID:D000310] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
6.7 | discontinued in phase 1 | unknown |
| figitumumab | insulin-like growth factor i receptor | NA | Successful target | TTD , DGIDB | Adrenal Cancer[MeSHID:D000310] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
6.7 | discontinued in phase 1 | antibody |
| click here to return to the previous page | ||||||||